| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.2 | 0.06 |